These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 28608263)

  • 1. Molecular markers of DNA damage and repair in cervical cancer patients treated with cisplatin neoadjuvant chemotherapy: an exploratory study.
    Real NE; Castro GN; Darío Cuello-Carrión F; Perinetti C; Röhrich H; Cayado-Gutiérrez N; Guerrero-Gimenez ME; Ciocca DR
    Cell Stress Chaperones; 2017 Nov; 22(6):811-822. PubMed ID: 28608263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of temozolomide (TMZ) on the expression and interaction of heat shock proteins (HSPs) and DNA repair proteins in human malignant glioma cells.
    Castro GN; Cayado-Gutiérrez N; Zoppino FC; Fanelli MA; Cuello-Carrión FD; Sottile M; Nadin SB; Ciocca DR
    Cell Stress Chaperones; 2015 Mar; 20(2):253-65. PubMed ID: 25155585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of p53 and apoptosis of tumor cells in locally advanced cervical carcinoma after cisplatin based neoadjuvant chemotherapy.
    Garzetti GG; Ciavattini A; Provinciali M; Di Stefano G; Lucarini G; Goteri G; Biagini G
    Anticancer Res; 1996; 16(5B):3229-34. PubMed ID: 8920796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PARP1 impact on DNA repair of platinum adducts: preclinical and clinical read-outs.
    Olaussen KA; Adam J; Vanhecke E; Vielh P; Pirker R; Friboulet L; Popper H; Robin A; Commo F; Thomale J; Kayitalire L; Filipits M; Le Chevalier T; André F; Brambilla E; Soria JC
    Lung Cancer; 2013 May; 80(2):216-22. PubMed ID: 23410825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Notch1 inhibition enhances DNA damage induced by cisplatin in cervical cancer.
    Li S; Ren B; Shi Y; Gao H; Wang J; Xin Y; Huang B; Liao S; Yang Y; Xu Z; Li Y; Zeng Q
    Exp Cell Res; 2019 Mar; 376(1):27-38. PubMed ID: 30690027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hsp27, Hsp70 and mismatch repair proteins hMLH1 and hMSH2 expression in peripheral blood lymphocytes from healthy subjects and cancer patients.
    Nadin SB; Vargas-Roig LM; Drago G; Ibarra J; Ciocca DR
    Cancer Lett; 2007 Jul; 252(1):131-46. PubMed ID: 17276589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity of ASPP and P-gp to neoadjuvant chemotherapy combined with gene therapy in locally advanced cervical cancer.
    Xiao J; Zhou J; Liang L; Liu F; Liang H; Xu C; Meng J
    J BUON; 2019; 24(3):967-974. PubMed ID: 31424649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic identification of predictive tissue biomarkers of sensitive to neoadjuvant chemotherapy in squamous cervical cancer.
    Guo L; Zhang C; Zhu J; Yang Y; Lan J; Su G; Xie X
    Life Sci; 2016 Apr; 151():102-108. PubMed ID: 26947588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic implication of HSPA (HSP70) in breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy.
    Nadin SB; Sottile ML; Montt-Guevara MM; Gauna GV; Daguerre P; Leuzzi M; Gago FE; Ibarra J; Cuello-Carrión FD; Ciocca DR; Vargas-Roig LM
    Cell Stress Chaperones; 2014 Jul; 19(4):493-505. PubMed ID: 24307543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aldehyde Dehydrogenase 1 Expression Predicts Chemoresistance and Poor Clinical Outcomes in Patients with Locally Advanced Cervical Cancer Treated with Neoadjuvant Chemotherapy Prior to Radical Hysterectomy.
    Xie Q; Liang J; Rao Q; Xie X; Li R; Liu Y; Zhou H; Han J; Yao T; Lin Z
    Ann Surg Oncol; 2016 Jan; 23(1):163-70. PubMed ID: 25916979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Clinical Significance of Phosphorylated Heat Shock Protein 27 (HSPB1) in Pancreatic Cancer.
    Okuno M; Adachi S; Kozawa O; Shimizu M; Yasuda I
    Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26805817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA Damage Repair Proteins, HSP27, and Phosphorylated-HSP90α as Predictive/Prognostic Biomarkers of Platinum-based Cancer Chemotherapy: An Exploratory Study.
    Sottile ML; Cuello-Carrión FD; Gómez LC; Semino S; Ibarra J; García MB; Gonzalez L; Vargas-Roig LM; Nadin SB
    Appl Immunohistochem Mol Morphol; 2022 Jul; 30(6):425-434. PubMed ID: 35639358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combinatorial treatment of ovarian cancer cells with harringtonine and cisplatin results in increased cisplatin-DNA adducts.
    Yunmbam MK; Guo Y; Miller MR; Yu JJ
    Oncol Rep; 2004 Apr; 11(4):833-8. PubMed ID: 15010881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and Side Effects of Irinotecan Combined with Nedaplatin versus Paclitaxel Combined with Cisplatin in Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer and Tumor Marker Analysis: Based on a Retrospective Analysis.
    Jiang Y; Song B; Chen Z
    Comput Math Methods Med; 2022; 2022():5936773. PubMed ID: 35693259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microsatellite instability is not related to response to cisplatin-based chemotherapy in cervical cancer.
    Ercoli A; Ferrandina G; Genuardi M; Zannoni GF; Cicchillitti L; Raspaglio G; Carrara S; Mancuso S; Scambia G
    Int J Gynecol Cancer; 2005; 15(2):308-11. PubMed ID: 15823117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin causes DNA damage and affects associated protein expression in HeLa human cervical cancer cells.
    Shang HS; Chang CH; Chou YR; Yeh MY; Au MK; Lu HF; Chu YL; Chou HM; Chou HC; Shih YL; Chung JG
    Oncol Rep; 2016 Oct; 36(4):2207-15. PubMed ID: 27499229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy with cisplatin and paclitaxel in locally advanced cervical cancer: has this regimen still a role as neoadjuvant setting?
    Moioli M; Papadia A; Mammoliti S; Pacella E; Menoni S; Menada MV; Ragni N
    Minerva Ginecol; 2012 Apr; 64(2):95-107. PubMed ID: 22481620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clusterin expression inversely correlates with chemosensitivity and predicts poor survival in patients with locally advanced cervical cancer treated with cisplatin-based neoadjuvant chemotherapy and radical hysterectomy.
    Watari H; Kanuma T; Ohta Y; Hassan MK; Mitamura T; Hosaka M; Minegishi T; Sakuragi N
    Pathol Oncol Res; 2010 Sep; 16(3):345-52. PubMed ID: 20058210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive significance of DNA damage and repair biomarkers in triple-negative breast cancer patients treated with neoadjuvant chemotherapy: An exploratory analysis.
    Vici P; Di Benedetto A; Ercolani C; Pizzuti L; Di Lauro L; Sergi D; Sperati F; Terrenato I; Dattilo R; Botti C; Fabi A; Ramieri MT; Mentuccia L; Marinelli C; Iezzi L; Gamucci T; Natoli C; Vitale I; Barba M; Mottolese M; De Maria R; Maugeri-Saccà M
    Oncotarget; 2015 Dec; 6(40):42773-80. PubMed ID: 26544894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase II study of neoadjuvant combination chemotherapy with docetaxel, cisplatin, and S-1 for locally advanced resectable gastric cancer: nucleotide excision repair (NER) as potential chemoresistance marker.
    Hirakawa M; Sato Y; Ohnuma H; Takayama T; Sagawa T; Nobuoka T; Harada K; Miyamoto H; Sato Y; Takahashi Y; Katsuki S; Hirayama M; Takahashi M; Ono M; Maeda M; Takada K; Hayashi T; Sato T; Miyanishi K; Takimoto R; Kobune M; Hirata K; Kato J
    Cancer Chemother Pharmacol; 2013 Mar; 71(3):789-97. PubMed ID: 23338051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.